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A new isolation and purification method for bioproducts 
using membrane-encapsulated affinity adsorbents was 
investigated. The new method involves encapsulation of 
affinity adsorbents, batch adsorption of the bioproduct 
from whole fermentation broth and rapid batch desorp- 
tion after dissolution of the capsule membranes. Recov- 
ery of protein A from Staphylococcus aureus was used 
as the model experimental system. Affinity adsorbents 
such as rabbit IgG-agarose were successfully encapsu- 
lated within calcium alginate membranes and used di- 
rectly to recover protein A from whole cell homogenate 
containing a number of macromolecular contaminants 
as well as suspended solids. Both high yield and high 
purity of protein A were recovered by this method in 
comparison with various previously reported methods. 
INTRODUCTION 
There has been much recent interest in the application of 
affinity adsorption in bioseparation processes. The high se- 
lectivity of biospecific ligands makes affinity adsorption 
especially attractive for isolation and purification of native 
and recombinant proteins and polypeptides from culture 
broths. Ideally, the use of affinity adsorption in early 
stages of downstream processing can be expected to signifi- 
cantly increase the final bioproduct yield. Although a 
number of investigators halve reported the successful use of 
affinity chromatography for purification of various bio- 
products, affinity adsorption is still primarily used at the 
final purification stage of a separation process and to pu- 
rify small quantities of a bioproduct from relatively clean 
solutions free of suspended solids. ’ Conventional solids 
separation methods such as centrifugation and filtration are 
often inefficient in removing suspended solids and colloids 
from whole culture broth.2 When chromatographic grade 
affinity adsorbents are used directly in batch adsorption 
from whole broths, fouling or pore blockage of the adsor- 
bent often occur because of adhesion of suspended solids 
or nonspecific adsorption of macromolecules onto the ad- 
sorbent surface. Also, the size of such adsorbents, usually 
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50-100 p m  diameter, is generally too small to allow easy 
recovery from the viscous broth. 
The idea of using affinity adsorbents in combination 
with aqueous two-phase at the whole broth 
stage has been proposed recently to circumvent these prob- 
lems. Affinity adsorbents with the adsorbed bioproduct are 
recovered from the broth by two-phase partitioning, since 
the adsorbents move to one phase while contaminants such 
as cell debris move to the other phase. Problems associated 
with reagent costs may occur when using this technique for 
large scale processing. Using immobilized adsorbents by 
entrapping chromatographic grade ion exchange resins in- 
side various hydrogel beads or capsules of 1-4 mm diameter 
may offer several advantages, including reduced suscepti- 
bility of adsorbents to f ~ u l i n g . ” ~  
Our approach using membrane encapsulated affinity ad- 
sorbents for whole broth processing proposed and investi- 
gated in this work is illustrated in Figure 1 .  First of all, 
affinity adsorbents are encapsulated within hydrogel mem- 
brane capsules which have well-defined characteristics 
such as size, membrane thickness, and pore size. Encapsu- 
lated adsorbents are then used in batch adsorption from 
whole cell homogenate. When adsorption is completed, 
the encapsulated adsorbents can easily be recovered by 
screening or other techniques and washed to remove vari- 
ous contaminant macromolecules and debris. Desorption 
of a desired bioproduct can be carried out with or without 
dissolving the capsule membranes. After desorption, the 
adsorbents can be reused without significant changes of the 
adsorption properties. 
The advantages of this concept can be explained as fol- 
lows: The membrane encapsulated adsorbents that are 
placed in the whole broth allow a desired bioproduct to 
preferentially diffuse through the capsule membranes but 
reject the permeation of various macromolecular contami- 
nants and suspended solids. Therefore, the adsorbents can 
be protected against nonspecific adsorption and contamina- 
tion by other macromolecular proteins and various sus- 
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Figure 1. 
bents at whole broth stage. 
Bioproduct recovery process using encapsulated affinity adsor- 
pended solids. The capsules may also protect the adsorbents 
from mechanical damage due to handling and stirring dur- 
ing processing. The size of the capsules can now be de- 
signed to be large enough for easy and complete recovery 
from the whole broth without undergoing additional filtra- 
tion or centrifugation. Since the capsule membranes can be 
easily dissolved, rapid desorption after releasing the adsor- 
bents from the capsules can be carried out, and the adsor- 
bents can be easily encapsulated again for reuse. 
The model experimental system chosen for this investi- 
gation is the direct recovery of Staphylococcal protein A 
(SpA) from whole cell homogenate using rabbit IgG-agarose 
encapsulated inside calcium alginate membranes. Staphy- 
lococcal Protein A is a cell wall protein produced by the 
bacterium Staphylococcus aureus and is biospecifically re- 
active with the F, region of various immunoglobulin species 
without interacting at their antigenic sites. Immobilized 
protein A has been shown to bind with different immuno- 
globulin species to a varying Protein A labeled 
with a tracer group can be used to detect and quantify anti- 
bodies and antigens. Also, protein A immobilized onto a 
solid support can be used for the purification of antibodies, 
cell separation, e t ~ . ~ ’ ~  Some physicochemical properties of 
protein A were described by Bjork and co-workers.” The 
conventional separation process of protein A is quite com- 
plex and involves multiple steps. The initial step is usually 
lysostaphin digestion of the bacterial cells to solubilize the 
cell wall Protein A. ” Subsequent processing involves cen- 
trifugation to remove solids, acid precipitation, filtration or 
a second centrifugation, ion-exchange chromatography, 
and affinity chr~matography.’~~~ Generally speaking, this 
multi-step separation process is time consuming and results 
in low overall product yield. 
The objective of this work is to investigate the feasibil- 
ity of a new separation scheme for protein A isolation and 
purification using the encapsulated IgG-agarose within cal- 
cium alginate membranes as shown in Figure l .  
MATERIALS AND METHODS 
Materials 
Staphylococcus aureus, Cowan I, (ATCC No. 12598) 
was obtained from American Type Culture Collection. The 
following chemicals were purchased from Sigma (St. Louis, 
MO): rabbit IgG-agarose, protein A, lysostaphin, DNAse, 
dextran (molecular weight of 42.6 X lo3), HEPES, and 
Tween 20. Sodium alginate, trade name Kelco Gel LV, 
was obtained from Kelco (Chicago, IL). Other chemicals 
used were of research grade. 
Preparation of Cell Homogenate 
Staphylococcus aureus was grown as described in the 
literature.” The culture medium was comprised of 14.3 g/L 
trypticase soy broth, 5.67 g/L yeast extract, 5.67 g/L glu- 
cose, and 5.67 g/L tri-(hydroxymethy1e)-aminomethane in 
distilled water. The culture was grown for 10 h at 37°C. 
Cells were harvested by centrifugation at 4°C and washed 
three times with 25mM HEPES buffer (pH 7.2). 
About 30 mL of thus obtained bacterial cell paste was 
resuspended in 300 mL of 25mM HEPES containing 145mM 
sodium chloride (pH 7.5) and heated to 37”C, shaking 
slowly. After this suspension reached 37”C, 0.75 mg/L 
lysostaphin and 0.15 mg/L DNAse were added, and the 
mixture was slowly shaken for 3 h at 37°C. Thus obtained 
homogenate was stored at - 30°C. Concentrations of pro- 
tein A, contaminant proteins and suspended solids in the 
homogenate were estimated to be 108, 1170, and 1300 mg 
dry wt/L, respectively. Assay procedures are described later. 
Encapsulation of Rabbit IgG-Agarose 
Precise dosages of rabbit IgG-agarose were suspended in 
25mM HEPES buffer containing 0.5% (w/v) calcium 
chloride and 20% (w/v) dextran (pH 7.2). Dextran was 
used as a viscosity enhancer.I3 Droplets of this suspension 
were introduced into 0.5% (w/v) sodium alginate solution 
in 25mM HEPES buffer (pH 7.2). The adsorbents were in- 
stantaneously wrapped inside a calcium alginate gel mem- 
brane due to rapid crosslinking of the anionic polymer, 
alginate, with divalent calcium cations. Capsules contain- 
ing IgG-agarose were recovered from the alginate solution, 
washed three times with lOmM HEPES (pH 7.2) and sub- 
sequently placed in lOmM HEPES buffer containing 0.5% 
(w/v) calcium chloride (pH 7.2) for 10 min to shrink and 
harden the capsule membranes. Encapsulated adsorbents 
thus prepared were stored in the HEPES buffer containing 
0.15M sodium chloride (pH 7.2) at 4°C until use. The size 
of capsules could be varied by using a droplet generator 
similar to the one described by Klein and co-workers.14 Ef- 
fective diffusivity of protein A in 0.5% calcium alginate 
gel was experimentally determined using gel beads in a 
similar manner to that described in the literature.’’ 
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Adsorption 
Adsorption equilibrium of protein A from protein A so- 
lutions onto free IgG-agiuose and from cell homogenates 
onto encapsulated IgG-agarose were obtained through 
batch adsorption studies. We examined the effects of the 
encapsulation and the presence of various contaminants 
and cell debris in the honiogenate on the adsorption capac- 
ity of IgG-agarose. In the case of free IgG-agarose, 0.1- 
0.5 mL IgG-agarose were directly added into 5 mL of 
100-200 pg/mL protein A solutions prepared by using 
25mM HEPES buffer (pH 7.2). In the case of encapsulated 
IgG-agarose, 2 mL capsules containing 0.1-0.5 mL IgG- 
agarose were added into 5 mL cell homogenate prepared as 
previously described. The suspensions were well stirred on 
a rotator in a constant temperature room at 4°C for over 
12 h. Initial and final equilibrium protein A concentrations 
were measured as described later. Initial and final concen- 
trations of contaminant proteins were also measured. 
RESULTS AND DISCUSSION 
Recovery and Wash of Encapsulated Adsorbents 
Encapsulated adsorbents were recovered from the sus- 
pensions using a stain1e:ss steel mesh and washed with 
10 mL of lOmM HEPES buffer (pH 7.2). The protein A 
concentration in the solution used for washing was also 
determined. 
Desorption 
Sodium citrate solution 5 mL of 1% (w/v) was added to 
dissolve 2 mL of the recovered and washed capsules con- 
taining IgG-agarose. After the complete dissolution of cap- 
sule membranes and sedimentation of the adsorbents, the 
protein A concentration in the discarded supernatant was 
measured. Afterwards 5 mL of O.1M glycine containing 
0.5M sodium chloride (pH 2.5) at 4°C was added to re- 
lease the protein A. The isuspension was shaken on a rota- 
tor in a constant temperature room at 4°C for over 12 h. 
Final protein A concentration was determined. 
Protein A Assay 
Protein A was assayed by a competitive ELISA method 
using protein A-peroxidase conjugate according to the pro- 
cedure described by Considine and co-workers16 with some 
modifications. Orthophenylenediamine and hydrogen per- 
oxide concentrations were 1 mg/ml and 0.03%, respec- 
tively. All the samples for protein A assay were diluted 
precisely 1 / 10- 1 / 100 with l O m M  Na,HPO,/NaH,PO, 
buffer containing 0.2M sodium chloride and 0.1% (v/v) 
Tween 20 (pH 7.2) so that protein A concentration was 
below 2 pg/mL. 
Protein Assay 
Concentration of contaminant proteins was determined 
by Bradford Protein Assay" using human serum albumin 
as the standard. 
Encapsulation of Affinity Adsorbents 
Basic approaches for encapsulation of bioactive mate- 
rials, including affinity adsorbents, developed in our labo- 
ratory are described elsewhere with several examples of 
 application^.^"^ The main advantages of our encapsulation 
approaches are I)  the procedure of encapsulation has been 
simplified, 2) materials to be encapsulated do not come 
into contact with the gel-forming polymers, and 3) capsule 
membrane characteristics can be controlled. This suggests 
that our approach may be suitable for large-scale encapsu- 
lation and processing of bioactive materials including af- 
finity adsorbents. 
Making good spherical capsules with uniform size and 
membrane thickness is important, as it is in other applica- 
tions. Particularly in the case of encapsulating adsorbents 
for downstream processing, we need to know the effective 
diffusivity of the desired protein product in the capsule 
membranes. In other words, capsule membranes should be 
designed to have pores large enough for the passages of 
the specific protein molecules. Effective diffusivities of 
glucose, ethanol and proteins in calcium alginate gel have 
been investigated by various researchers'4315~'8-20 and it is 
known that the effective diffusivities are significantly de- 
pendent on the concentration of sodium alginate and may 
vary with the source and the lot of the sodium alginate 
preparations. Figure 2 shows the diffusion of protein A 
into the calcium alginate beads prepared from a 0.5% 
(w/v) sodium alginate solution. Solid lines in Figure 2 
represent the theoretical profiles" given by eqs. (1)-(3), 
when the effective diffusivity in the gel beads, D,, is the 
same as that in bulk solution, D,, and when the value 
of the effective diffusivity is only one-third of the bulk 
value. The latter seems to fit the experimental data more 
accurately. 
C 6(1 + a)  exp(-D,qit/Ri) 
c, l + a  n = I  9 + 9a + q:a2 
(1) 
where a = V,/V,, V, and V, represent the volume of pro- 
tein A solution and gel bead respectively, and qn terms are 
the roots of eq. (2): 
(2) 
All beads used were assumed to be spherical and the mean 
radius of the beads, R,, were determined from eq. (3) 
tan qn = 3q,/(3 + wi) 
V, = 4 ~ R i N / 3  ( 3 )  
where N is the number of beads used. 
We can prepare membranes with larger pores in order to 
reduce the diffusion resistance in the membrane by de- 
creasing the sodium alginate concentration or by employ- 
ing different sources of alginate preparations. However, 
the mechanical strength of the capsules prepared using less 
than 0.5% (w/v) sodium alginate solutions was not strong 
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enough to withstand mechanical stress due to stirring. Be- 
cause of this, rabbit IgG-agarose were encapsulated within 
hydrogel membranes prepared from 0.5% (w/v) sodium 
alginate solution. A picture of the prepared encapsulated 
IgG-agarose is shown in Figure 3. 
Adsorption of Protein A 
Figure 4 gives adsorption equilibrium of protein A with 
IgG-agarose at 4"C, pH 7.2. The amount of protein A ad- 
sorbed onto the IgG-agarose was evaluated based on the 
following equation: 
(4) 
where q is the amount adsorbed in equilibrium with the fi- 
nal concentration; C,, C,, is the initial concentration; and 
V, , V, and V, are the volumes of a protein A solution or the 
cell homogenate, IgG-agarose, and the void in capsules re- 
spectively. V, + V, represents the total volume of the cap- 
sules containing IgG-agarose. For free IgG, V, is equal to 
0. 
Open square symbols represent the adsorption from pro- 
tein A solutions onto free IgG-agarose, and the solid 
square symbols represent the adsorption data from the cell 
homogenate using encapsulated IgG-agarose. As shown in 
Figure 4, the adsorption capacity in both cases is approxi- 
mately 1 mg/mL (IgG-agarose gel) regardless of the ad- 
sorbent preparations or the sources of the protein A. Thus, 
the encapsulation process does not harm the rabbit IgG lig- 
and, and the adsorption capacity of the encapsulated adsor- 
bents is not reduced when they are used directly in the cell 
homogenate. Also, it should be noted that the shape of the 
isotherm belongs to the so-called rectangular isotherm in- 
dicating nearly complete recovery of protein A by batch 
adsorpion is possible. Nonspecific adsorption of protein A 
onto capsules not containing IgG-agarose was not experi- 
mentally observed. Figure 5 indicates that 12 h is sufficient 
for obtaining adsorption equilibrium data. 
Figure 5 shows adsorption profiles of protein A from the 
cell homogenate using three different membrane encapsu- 
lated rabbit IgG-agarose of various sizes. Rapid adsorption 
(solid square symbols) was observed when 0.5 mL free Ig- 
G-agarose was placed into 5 mL cell homogenate. Adsorp- 
tion profiles represented by open square and triangle 
Figure 3. Encapsulated rabbit IgG-agarose. 
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Figure 4. Adsorption capacity of free and encapsulated IgG-agarose. 
symbols in Figure 5 were observed when 2 mL capsules 
containing 0.5 mL IgG-agarose, of sizes 1 and 2 mm in 
diameter, respectively, were placed into 5 mL cell ho- 
mogenate. The adsorption rate of protein A onto encapsu- 
lated adsorbents was found to be dependent on the capsule 
size. Therefore, the adsorption rate is most likely con- 
trolled by the diffusion inside the capsule including the 
capsule membrane. Generally, the smaller the size of the 
capsule, the faster the aldsorption rate was experimentally 
observed. However, for the sake of easy recovery of the en- 
capsulated adsorbents from the cell hoplogenate, the mini- 
mum size of the capsule is considered to be ca. 0.5 mm 
diameter. Contribution of the diffusion resistance inside 
the IgG-agarose gel to overall mass transfer resistance may 
not be negligible either. Additional theoretical analysis is 
currently being conducte:d in our laboratory to clarify this 
issue. The most important point is that the time of the ad- 
sorption step is dominant in this complete process and that 
the time is approximately a few hours, which is considered 
to be acceptable in comparison with other conventional 
multi-step processes.'~" 
Desorption of Protein A and Cyclic Use of 
IgG-Agarose 
Two minutes were found to be adequate for dissolving 
the capsule membranes completely using 1% (w/v) so- 
dium citrate solution. Also, desorption of protein A using 
120 I I 
A Encapsulated, d=2 rnm 
" 
0 100 200 300 400 500 6 0 0  
time [min] 
Figure 5. Adsorption rate to free and encapsulated IgG-agarose. 
Figure 6 .  
sorption and desorption. 
Change of the amount adsorbed of protein A during cyclic ad- 
O.1M glycine containing sodium chloride (pH 2.5) could 
be achieved in only 10 min. The average amount of de- 
sorbed protein A was ca. 900 pg/mL gel, which corre- 
sponds to nearly 90% of the total adsorbed product, and 
that of contaminant proteins was approximately 30 pg/mL 
gel. The purification factor defined by the following equa- 
tion was calculated to be 340: 
Purification factor = (SpA/CP)/(SpA,/CP,) (5 )  
where SPA and CP are the concentration of protein A and 
contaminant proteins, respectively. Subscript 0 represents 
the initial concentrations in the cell homogenate. Protein A 
was not detected in the solutions used for washing and dis- 
solving the capsules. 
Since 90% of protein A could be recovered using this 
method, th; product yield appears to be about 90% for a 
single pass. However, as long as we can reuse the adsor- 
bents in a cyclic mode for repeated use 100% recovery for 
a single pass may not be required. Plots in Figure 6 repre- 
sent the amount of protein A recovered by the encapsu- 
lated IgG-agarose during multiple cycles of adsorption and 
desorp'tion. The difference between the higher and the 
lower values can be regarded as the effective adsorption 
capacity in repeated adsorption and desorption cycles. No 
observed decrease in the effective adsorption capacity can 
be found throughout these cycles. 
Yields and Purification Factors 
Yields and purification factors for protein A recovery by 
this method and various other methods from the literature 
are compared in Table I. Since a pure protein A solution 
was used in the study of affinity partitioning using carrier 
adsorbents (a combination of affinity adsorbents and aque- 
ous two-phase partitioning), a purification factor could not 
be obtaiiled. Even in such an ideal case, the yield is 
shown to be only 12%.22 Direct adsorption using non- 
specific adsorbents from culture supernatant of a mutant 
which releases protein A extracellularly gives low yield 
and purification factors. Subsequent affinity chromatog- 
raphy improves the purity significantly, however, the over- 
all yield is still only 34%.23 Table I shows that our ap- 
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Table I. 
methods. 
Yields and purification factors of protein A by various isolation and purification 
Yield 
Method Source (%) PF Reference 
Adsorption using encapsulated cell homogenate by c 
affinity adsorbents lysostaphin digestion 
(batch desorption) 
including affinity chromatography lysostaphin digestion 
carrier adsorbents 
(column elution) 
Direct adsorption using 
ion-exchange adsorbents 
Affinity chromatography 
Conventional multistep isolation 
Affinity partitioning using 
cell homogenate by 
protein A solution 
supernatant of culture 
media of a mutant 
:a. 100 ca. 340 this work 
<60 NA 7, 12 
72 - 22 
64 7.3 23 
34 554 23 
proach results in both higher yield and higher purity than 
these existing methods. 
CONCLUSIONS 
A new simple isolation and purification method using 
membrane encapsulated affinity adsorbents at the whole 
broth stage was successfully demonstrated for the direct re- 
covery of Staphylococcal protein A from whole cell ho- 
mogenate. The affinity adsorbent rabbit IgG-agarose was 
successfully encapsulated within calcium alginate mem- 
branes and used in the direct recovery of protein A from 
cell homogenate. Rapid batch desorption was carried out 
by dissolving the capsule membranes and the used IgG- 
agarose could be recycled and reused in cyclic mode with- 
out considerable decrease in effective adsorption capacity. 
Both high yield and high purity of protein A from whole 
cell homogenate were achieved using membrane encapsu- 
lated affinity adsorbents. 
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Science Foundation (grant nos. ECE-86- 12969 and CBT-88- 
12996). 
References 
1. H.A. Chase, Chem. Eng. Sci., 39, 1009 (1984). 
2. S .  C. Nigam, A. Sakoda, and H. Y. Wang, Biotechnol. Prog., 4, 166 
(1988). 
3. P. Hedman and J.  G .  Gustafsson, Anal. Biochem., 138, 411 (1984). 
4. A. K. Frej, J. G .  Gustafsson, and P. Hedman, Biochem. Bioeng., 28, 
5 .  H. Y. Wang and K. Sobnosky, ACS Symp. Ser., 271, 123 (1986). 
6. A. Forsgren and J. Sjoquist, J .  Immun., 97, 822 (1966). 
7. H. Hjelm, K. Hjelm, and J.  Sjoquist, FEBS Lett., 28, 73 (1972). 
8. 3.  J. Longone, J .  Immunol. Methods, 55, 277 (1982). 
9. J.  W. Goding, J .  Immunol. Methods, 20, 241 (1978). 
133 (1986). 
10. I. Bjork, B. Peterson, and J. Sjoquist, Eur. J .  Biochem., 29, 579 
11. C. A. Schindler and U. T. Schuhardt, Proc. Nat .  Acad. Sci., U . S . A . ,  
12. J. Sjoquist, B. Meloun, and H. Hjelm, Eur. J .  Biochem., 29, 572 
13. S.C.  Nigam, I-Fu Tsao, A. Sakoda, and H.Y. Wang, Biotechnol. 
14. J .  Klein, 3. Stock and K. D. Vorlop, Eur. J .  Appl. Microb. Biotech- 
15. H. Tanaka, M. Matsumura, and I .  A. Veliky, Biotechnol. Bioeng., 
16. P. J. Considine, P. Duggan, and A. Eadie, Biosci. R e p . ,  6 ,  933 
17. M. M. Bradford, Anal. Biochem., 72, 248 (1976). 
18. M. Kierstan, G .  Darcy, and J. Reilly, Biotechnol. Bioeng., 24, 1507 
19. B. J. M. Hannoun and G .  Stephanopoulos, Biotechnol. Bioeng., 28, 
20. G .  F. Itamunoala, Biotechnol. Prog., 3, 115 (1987). 
21. J. Crank, Chapter 6: “Diffusion in a Sphere” in Mathematics of D$ 
22. P. Hedman and J. G .  Gustafsson, Anal. NY Acad Sci., 434, 285 
23. K. Seki, S. Nishihara, and S. Masuda, Microbial. Immunol., 29, 
(1972). 
54, 414 (1964). 
(1972). 
Techniques, 2, 271 (1988). 
nol., 18, 86 (1983). 




fusion (Clarendon, Oxford, 1956). 
(1984). 
559 (1985). 
SAKODA AND WANG: ISOLATION/PURlFlCATlON OF PROTEIN A 1103 
